Montreal, Quebec, CANADA, March 31, 2005 – PainCeptor Pharma, a privately held Canadian biotechnology company specializing in the development of therapeutic compounds for the treatment of acute and chronic pain, announced today the appointment of Dr. Francine Gervais, Ph. D., to the position of Senior Vice-President and Vice-President of Pharmaceutical Development.
